Edward Kaye
Chief Executive Officer at STOKE THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Edward M.
Kaye is currently the Chief Executive Officer & Director at Stoke Therapeutics, Inc., an Independent Director at Cytokinetics, Inc., an Independent Director at Avidity Biosciences, Inc., a Director at Massachusetts Biotechnology Council, and an Advisory Board Member at CureDuchenne Ventures LLC.
Previously, he served as an Independent Director at NeuroVia, Inc., a Director at Sarepta Therapeutics, Inc., a Group Vice President-Clinical Development at Genzyme Corp., and the Chief-Neurology at St. Christopher's Hospital for Children LLC.
He also held positions as an Associate Professor at Perelman School of Medicine and Chief-Biochemical Genetics at The Children's Hospital of Philadelphia.
Dr. Kaye received his undergraduate degree from Loyola University New Orleans and his doctorate from Stritch School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-01-01 | 19,317 ( 0.02% ) | 1 M $ | 2024-03-30 | |
STOKE THERAPEUTICS, INC.
0.15% | 2024-03-18 | 69,350 ( 0.15% ) | 936 225 $ | 2024-03-30 |
AVIDITY BIOSCIENCES INC
-.--% | 2023-06-14 | 0 ( -.--% ) | - $ | 2024-03-30 |
Edward Kaye active positions
| Companies | Position | Start |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Director/Board Member | 2016-05-19 |
| STOKE THERAPEUTICS, INC. | Chief Executive Officer | 2017-09-30 |
| AVIDITY BIOSCIENCES, INC. | Director/Board Member | 2019-08-21 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Director/Board Member | 2016-02-29 |
CureDuchenne Ventures LLC
 CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | Consultant / Advisor | - |
Former positions of Edward Kaye
| Companies | Position | End |
|---|---|---|
| SAREPTA THERAPEUTICS, INC. | Chief Executive Officer | 2017-06-30 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2011-05-31 |
St. Christopher's Hospital for Children LLC
 St. Christopher's Hospital for Children LLC Medical/Nursing ServicesHealth Services St. Christopher's Hospital for Children LLC provides pediatric, children care services, family advisory council, nurturing and culturally diverse environment. Its services include anesthesiology, audiology, cardiology, and center for the urban child, child life program, child protection program, critical care, dental medicine, developmental pediatrics, ear nose throat, emergency, hepatology nutrition and genetics. The company was founded by William H. Bennett on November 30, 1875 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 1997-12-31 |
The Children's Hospital of Philadelphia
 The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Edward Kaye
| Loyola University New Orleans | Undergraduate Degree |
| Stritch School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| AVIDITY BIOSCIENCES, INC. | Health Technology |
| STOKE THERAPEUTICS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Commercial Services |
St. Christopher's Hospital for Children LLC
St. Christopher's Hospital for Children LLC Medical/Nursing ServicesHealth Services St. Christopher's Hospital for Children LLC provides pediatric, children care services, family advisory council, nurturing and culturally diverse environment. Its services include anesthesiology, audiology, cardiology, and center for the urban child, child life program, child protection program, critical care, dental medicine, developmental pediatrics, ear nose throat, emergency, hepatology nutrition and genetics. The company was founded by William H. Bennett on November 30, 1875 and is headquartered in Philadelphia, PA. | Health Services |
The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA. | Health Services |
NeuroVia, Inc.
 NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Neurovia, Inc. provides small molecule therapeutics for the treatment of neurologic disorders. The company was founded by Thomas Scanlan in 2014 and is headquartered in Cambridge, MA. | Health Technology |
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures LLC (CureDuchenne Ventures) is a venture capital subsidiary of CureDuchenne, founded in 2014 by Debra Miller. The firm is headquartered in Newport Beach, California. | Finance |
- Stock Market
- Insiders
- Edward Kaye
